glp 1 cgm The Sugar Queens: Continuous Glucose Monitoring and GLP-1 Receptor Agonists Diabetes Technology: A Primer for

They increase satiety

Never see you, just treat your insulin and treat your diabetes

While the clinical evaluation of GLP-1MK-801 for weight loss awaits, efforts to broaden the scope of developing peptide-mediated targeting of ion channels are encouraged and should not be restricted to metabolic diseases

While we will start out by performing the injections ourselves, certain patients who are good candidates may be able to start performing their own injections at home, if desired

Key structural drivers behind this growth: Rising obesity and lifestyle-related disorders in India Increasing awareness around metabolic health Expansion of preventive healthcare and diagnostics Price corrections as generics enter the market post-patent expiry Interestingly, analysts expect the first wave of generic GLP-1 launches in India around March 2026, potentially triggering aggressive price competition and expanding accessibility